Comparing fexuprazan and rabeprazole for treating peptic ulcer: A multicenter, randomized controlled trial

doi:10.3748/wjg.119434

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 25

This Article

(17)

(20)

(0)

(344)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Clinical Trial

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jul 7, 2026; 32(25): 119434
Published online Jul 7, 2026. doi: 10.3748/wjg.119434

Full Size Figure Download Figure

Figure 3 Changes from baseline in serum gastrin levels at weeks 6 and 10 (per protocol set).

Citation: Lee DS, Lee SW, Kang SH, Moon HS, Sung JK, Kim SH, Lee DK, Kim KB, Kim SM, Cho YS, Kim JS. Comparing fexuprazan and rabeprazole for treating peptic ulcer: A multicenter, randomized controlled trial. World J Gastroenterol 2026; 32(25): 119434
URL: https://www.wjgnet.com/1007-9327/full/v32/i25/119434.htm
DOI: https://dx.doi.org/10.3748/wjg.119434

Lee DS, Lee SW, Kang SH, Moon HS, Sung JK, Kim SH, Lee DK, Kim KB, Kim SM, Cho YS, Kim JS. Comparing fexuprazan and rabeprazole for treating peptic ulcer: A multicenter, randomized controlled trial. World J Gastroenterol 2026; 32(25): 119434 [DOI: 10.3748/wjg.119434]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.